YorkTest Laboratories appoints new Chairman
Key Capital Partners invested in the MBO of YorkTest Laboratories in July 2017 and we are pleased to announce that the business has recently appointed David Mobbs as its new Chairman.
YorkTest is the UK market leader in food intolerance testing. The company offers comprehensive support to customers in identifying food intolerance and guiding them through dietary changes to address ailments such as IBS, migraines and skin conditions.
David is recognised as an innovative and influential healthcare leader and brings extensive experience in the wellness industry to the food intolerance testing company. As the former Group Chief Executive Officer of Nuffield Health, he devised and led the organisation’s transformation to become the UK’s only integrated private health provider.
Mr Mobbs said: “I’m honoured to have been appointed as Chairman of YorkTest Laboratories. The company has gone from strength to strength and the work they are doing is helping people and making a real impact on their lives. I’m looking forward to supporting YorkTest as they work towards becoming a truly global wellness-based company.”
The York-based food intolerance testing company began trading in just two countries, in the UK and Ireland, and now trades in 45.
YorkTest plans to expand further with three new country launches scheduled in the next two months alone.
Rachel Jansen, CEO, added: “We are delighted to have appointed David as our new Chairman. He is one of the most respected leaders in the healthcare sector and brings a wealth of experience and knowledge in the industry to YorkTest."
“This is the perfect time for us to appoint David at a stage when we are embarking on our global wellness strategy. We know he will be able to help us deliver our aim of being a worldwide leader in the healthcare sector."
"This is a really exciting time for us and we’re thrilled about the next chapter for YorkTest.”